Literature DB >> 12500706

Aphasia following left putaminal hemorrhage. Statistical analysis of factors affecting prognosis.

Masahiro Kawanishi1, Hiroshi Kajikawa, Kunio Yamamura, Eiichi Nomura, Minako Kajikawa, Rinko Hihara, Ryusuke Ogawa, Shiro Nagasawa.   

Abstract

Multivariate and single variable analyses were employed to investigate the recovery mode of aphasia in right-handed patients with putaminal hemorrhage on the left side. Speech disturbance was evaluated using the standard language test for aphasia (SLTA) at intervals of 1, 3 and 6 months after the ictus. Recovery was assessed in relation to age, gender, volume and location of hematoma, and treatment modalities. Extension of the hematoma into the corona radiata was the factor that dominated the prognosis of aphasia at all intervals during the follow-up period. Good recovery was documented in patients with less than 2 cm2 of the hematoma volume located in the corona radiata. Recovery was poor, however, in patients with more than 12 cm2 of the hematoma in the corona radiata. While aphasia continued to improve over 6 months after the ictus, recovery was more prominent in the first 3 months. Our study precisely demonstrated that the extension into the corona radiata independently and strongly influenced the outcome of aphasia in patients with left putaminal hemorrhage.

Entities:  

Mesh:

Year:  2002        PMID: 12500706     DOI: 10.1179/016164102101200780

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  2 in total

1.  The role of dominant striatum in language: a study using intraoperative electrical stimulations.

Authors:  S Gil Robles; P Gatignol; L Capelle; M-C Mitchell; H Duffau
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

2.  The importance of premotor cortex for supporting speech production after left capsular-putaminal damage.

Authors:  Mohamed L Seghier; Juliana Bagdasaryan; Dorit E Jung; Cathy J Price
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.